Alexion to Pay $8.4 Billion to Buy Synageva in Rare-Disease Push
Alert: HALISTER Source: BN (Bloomberg News)
Tickers ALXN US (Alexion Pharmaceuticals Inc) GEVA US (Synageva BioPharma Corp)
People David Hallal (Alexion Pharmaceuticals Inc)
To de-activate this alert, run {NLRT DEACT HALISTER <GO>}. To modify this alert, run {NLRT EDIT HALISTER <GO>}.
UUID: 7947283